These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18513880)

  • 1. A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme.
    Drappatz J; Wong ET; Schiff D; Kesari S; Batchelor TT; Doherty L; Lafrankie DC; Ramakrishna N; Weiss S; Smith ST; Ciampa A; Zimmerman J; Ostrowsky L; David K; Norden A; Barron L; Sceppa C; Black PM; Wen PY
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):222-7. PubMed ID: 18513880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors.
    Fine HA; Kim L; Albert PS; Duic JP; Ma H; Zhang W; Tohnya T; Figg WD; Royce C
    Clin Cancer Res; 2007 Dec; 13(23):7101-6. PubMed ID: 18056189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies.
    Sharma RA; Steward WP; Daines CA; Knight RD; O'Byrne KJ; Dalgleish AG
    Eur J Cancer; 2006 Sep; 42(14):2318-25. PubMed ID: 16899362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lenalidomide therapy for metastatic renal cell carcinoma.
    Amato RJ; Hernandez-McClain J; Saxena S; Khan M
    Am J Clin Oncol; 2008 Jun; 31(3):244-9. PubMed ID: 18525302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of lenalidomide (Revlimid) in recurrent ovarian and primary peritoneal carcinoma.
    Zhang MM; Chan JK; Husain A; Guo HY; Teng NN
    Gynecol Oncol; 2007 Apr; 105(1):194-8. PubMed ID: 17257661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.
    Ford JM; Seiferheld W; Alger JR; Wu G; Endicott TJ; Mehta M; Curran W; Phan SC
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):831-8. PubMed ID: 17560737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
    Palumbo A; Falco P; Corradini P; Falcone A; Di Raimondo F; Giuliani N; Crippa C; Ciccone G; Omedè P; Ambrosini MT; Gay F; Bringhen S; Musto P; Foà R; Knight R; Zeldis JB; Boccadoro M; Petrucci MT;
    J Clin Oncol; 2007 Oct; 25(28):4459-65. PubMed ID: 17785703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.
    Krishnan S; Brown PD; Ballman KV; Fiveash JB; Uhm JH; Giannini C; Jaeckle KA; Geoffroy FJ; Nabors LB; Buckner JC;
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1192-9. PubMed ID: 16626884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.
    Choueiri TK; Dreicer R; Rini BI; Elson P; Garcia JA; Thakkar SG; Baz RC; Mekhail TM; Jinks HA; Bukowski RM
    Cancer; 2006 Dec; 107(11):2609-16. PubMed ID: 17075879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose tamoxifen treatment increases the incidence of multifocal tumor recurrences in glioblastoma patients.
    Puchner MJ; Giese A; Lohmann F; Cristante L
    Anticancer Res; 2004; 24(6):4195-203. PubMed ID: 15736473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide in the treatment of multiple myeloma: a review.
    Armoiry X; Aulagner G; Facon T
    J Clin Pharm Ther; 2008 Jun; 33(3):219-26. PubMed ID: 18452408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy for newly diagnosed glioblastoma: a pilot study in Tsukuba.
    Yamamoto T; Nakai K; Tsurubuchi T; Matsuda M; Shirakawa M; Zaboronok A; Endo K; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S25-6. PubMed ID: 19375927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.
    Glaspy J; Atkins MB; Richards JM; Agarwala SS; O'Day S; Knight RD; Jungnelius JU; Bedikian AY
    Cancer; 2009 Nov; 115(22):5228-36. PubMed ID: 19728370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.
    Treon SP; Soumerai JD; Branagan AR; Hunter ZR; Patterson CJ; Ioakimidis L; Chu L; Musto P; Baron AD; Nunnink JC; Kash JJ; Terjanian TO; Hyman PM; Nawfel EL; Sharon DJ; Munshi NC; Anderson KC
    Clin Cancer Res; 2009 Jan; 15(1):355-60. PubMed ID: 19118065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.
    Hazarika M; Rock E; Williams G; Dagher R; Sridhara R; Booth B; Farrell A; Justice R; Pazdur R
    Oncologist; 2008 Oct; 13(10):1120-7. PubMed ID: 18922829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme.
    Moyal EC; Laprie A; Delannes M; Poublanc M; Catalaa I; Dalenc F; Berchery D; Sabatier J; Bousquet P; De Porre P; Alaux B; Toulas C
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1396-401. PubMed ID: 17570606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
    Grabenbauer GG; Gerber KD; Ganslandt O; Richter A; Klautke G; Birkmann J; Meyer M
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):164-9. PubMed ID: 19695435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy for newly diagnosed glioblastoma.
    Yamamoto T; Nakai K; Kageji T; Kumada H; Endo K; Matsuda M; Shibata Y; Matsumura A
    Radiother Oncol; 2009 Apr; 91(1):80-4. PubMed ID: 19285355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common sense approach to radiotherapy planning of glioblastoma multiforme situated in the temporal lobe.
    Bokstein F; Kovner F; Blumenthal DT; Ram Z; Templehoff H; Kanner AA; Corn BW
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):900-4. PubMed ID: 18407432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
    Habermann TM; Lossos IS; Justice G; Vose JM; Wiernik PH; McBride K; Wride K; Ervin-Haynes A; Takeshita K; Pietronigro D; Zeldis JB; Tuscano JM
    Br J Haematol; 2009 May; 145(3):344-9. PubMed ID: 19245430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.